semaglutide and alcohol use disorder as a promising new treatment for GLP-1 reduces heavy drinking days

For weight management, NICE has approved: Semaglutide 2.4 mg (TA875) for adults with a BMI of 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) with at least one weight-related comorbidity, and for some people with BMI 30-34.9 kg/m meeting specific criteria

We've seen clients submit products for analysis that looked clear and normal but tested at pH 3.8

Experts stress that semaglutide works best as part of a broader treatment plan, which also includes regular physical activity and proper diet to improve both the efficacy and tolerability of the drug

Commitment to Lifestyle Changes : GLP-1 medications are most effective when paired with healthy habits